Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Australian Journal of General Practice|August 2, 2023
Management of hepatitis D in general practiceCarmela Cosentino, Daniel Clayton-Chubb, John S Lubel
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 20, 2022
Undiagnosed gastric adenocarcinoma causing progressive respiratory failureDaniel Clayton-Chubb, Ewan Chan, Daniel Schneider, et al.
Internal Medicine Journal|March 25, 2018
Thunderstorm asthma: revealing a hidden at-risk populationDaniel Clayton-Chubb, Danny Con, Kanishka Rangamuwa, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2021
Randomised clinical trial: adjunctive induction therapy with oral effervescent budesonide in newly diagnosed coeliac diseaseEvan D Newnham, Daniel Clayton-Chubb, Meena Nagarethinam, et al.
The Medical Journal of Australia|May 10, 2026
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic DysfunctionKarl Vaz, Daniel Clayton-Chubb, William W Kemp, et al.
Internal Medicine Journal|March 7, 2023
Initial outcomes of a dedicated multidisciplinary non-alcoholic fatty liver disease clinic: a retrospective cohort studyIsabella Commins, Daniel Clayton-Chubb, Sarah Melton, et al.
Nutrients|July 14, 2023
Reply to Abenavoli et al. Comment on "Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687"Daniel Clayton-Chubb, William Kemp, Ammar Majeed, et al.
Nutrients|February 11, 2023
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future PerspectivesDaniel Clayton-Chubb, William Kemp, Ammar Majeed, et al.
Digestive Diseases and Sciences|November 18, 2024
Predicting Immune Flares in Untreated Chronic Hepatitis B Patients Using Novel Risk Factors and the FLARE-B ScoreDanny Con, Daniel Clayton-Chubb, Steven Tu, et al.
Hepatology International|August 9, 2023
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomesKarl Vaz, Daniel Clayton-Chubb, Ammar Majeed, et al.
Pageof 4